Brief: Neurosense Therapeutics Announces Phase 2B Microrna Data
09/04/2025 13:39
April 9 (Reuters) - Neurosense Therapeutics Ltd NRSN.O: NEUROSENSE THERAPEUTICS ANNOUNCES TRANSFORMATIVE PHASE 2B MICRORNA DATA, HIGHLIGHTING PRIMEC'S PROMISE AS A DISEASE-MODIFYING ALS TREATMENT Source text: ID:nPn8yc17na Further company coverage: NRSN.O ((Reuters.Briefs@thomsonreuters.com;))